OICR News / Tag

Prospects Oncology Fund

Browse news tagged Prospects Oncology Fund.

Browse all news

Filters

Discover the latest news and insightsDiscover the latest news and insights

All Collaboration Commercialization Talent Technology

All Video Article

Tagged stories

Commercialization

FACIT backs made-in-Ontario data science and medtech innovations through Prospects Oncology Fund

Replica Analytics & Sunnybrook’s Czarnota Lab receive key seed funding to de-risk Ontario intellectual property TORONTO, ON (June 23, 2020) – FACIT, a commercialization venture firm, announced the newest recipients of Ontario First seed capital…

ArticleJun 23, 2020

Commercialization

Healthcare Software Start-Up Ziliomics Financed by FACIT

World-leading genomics cloud computing group builds clinical tool for cancer care in Ontario TORONTO, ON (June 27, 2018) – Ziliomics Inc., a start-up created by FACIT, received seed financing from the Prospects Oncology Fund. Derived…

ArticleJun 27, 2018

Commercialization

FACIT invests $450k in promising Ontario breakthrough technologies

Investment supports emerging entrepreneurial scientists and critical proof-of-principle studies TORONTO, ON (February 20, 2018) – FACIT, a business accelerator, announced four new recipients of funding through its Prospects oncology investment competition: Dalriada Therapeutics Inc. (“Dalriada”),…

ArticleFeb 21, 2018

Commercialization

FACIT announces investment in three Ontario start-ups under Prospects Fund

FACIT invests first round of Prospects Fund in Radialis Medical, KA Imaging, and DNAstack. TORONTO, ON (July 10, 2017) – FACIT has announced the first three investments under its new Prospects Oncology Fund for proof-of-concept development…

ArticleAug 01, 2017

Commercialization

FACIT Launches The Prospects Oncology Fund

New evergreen fund to help Ontario discoveries reach seed-stage funding faster TORONTO, March 21, 2017 /CNW/ - Fight Against Cancer Innovation Trust ("FACIT") is pleased to announce the launch of The Prospects Oncology Fund ("Prospects…

ArticleMar 22, 2017

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Prospects Oncology Fund

Discover the latest news and insightsDiscover the latest news and insights

Tagged stories

FACIT backs made-in-Ontario data science and medtech innovations through Prospects Oncology Fund

Healthcare Software Start-Up Ziliomics Financed by FACIT

FACIT invests $450k in promising Ontario breakthrough technologies

Cancer solved together — in your inbox

FACIT announces investment in three Ontario start-ups under Prospects Fund

FACIT Launches The Prospects Oncology Fund